13h
PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint
PDS Biotech Submits Amended Protocol for Phase 3 VERSATILE-003 TrialConstructive Type C Meeting Provides Potential Pathway to Accelerated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback